These results were similar as reported by Frazzi et al. [44], which indicated that by using an inhibitor of SIRT1 (resveratrol) the acetylation level of FOXO3a was strongly upregulated in the Hodgkin lymphoma cells. Here, SIRT1 is linked to Hodgkins lymphoma.